One interesting element to their drop today is that a lot of SYN shareholders claimed that Trimesta was already discounted from the share price. Of course the bad news still dropped the share price this morning. It's recovered somewhat but is still down sharply.

Point is, whether shareholders of a company think the market has completely discounted a compound, bad news regarding that compound will still be bad for the market cap.

While I believe P will be successful, I've read a lot of people say that it isn't even reflected in the MC and so bad results won't hurt too much. That seems false to me, but hopefully we never have to find out. Likewise, good results should propel CTIX MC.